Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidharth Mehan

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Pharmacology Research & Perspectives|October 3, 2024
Effect of mitochondrial coenzyme-Q10 precursor solanesol in gentamicin-induced experimental nephrotoxicity: Evidence from restoration of ETC-complexes and histopathological alterationsMinakshi Sangwan, Hema Chaudhary, Sidharth Mehan, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
RETRACTED: Rajkhowa et al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. <i>Pharmaceuticals</i> 2022, <i>15</i>, 959Bidisha Rajkhowa, Sidharth Mehan, Pranshul Sethi, et al.
Journal of Drug Targeting|February 8, 2024
Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategiesNitin Sharma, Balak Das Kurmi, Dilpreet Singh, et al.
European Journal of Medicinal Chemistry|September 18, 2024
Rationally designed febuxostat-based hydroxamic acid and its pH-Responsive nanoformulation elicits anti-tumor activityRitika, Zi-Yi Liao, Pin-Yu Chen, et al.
Molecules (Basel, Switzerland)|November 26, 2022
Effect of Natural Adenylcyclase/cAMP/CREB Signalling Activator Forskolin against Intra-Striatal 6-OHDA-Lesioned Parkinson's Rats: Preventing Mitochondrial, Motor and Histopathological DefectsMetab Alharbi, Abdulrahman Alshammari, Gurpreet Kaur, et al.
Current Pharmaceutical Design|January 27, 2025
Efficacy and Safety of Altibrain® as an Adjunctive Therapy for Autism Spectrum Disorder: An Open Label Trial Targeting Core SymptomsSidharth Mehan, Aakash Kumar, Prashant R Utage, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Exploring Azithromycin's Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory ModulationMohannad A Almikhlafi, Nehad A Abdallah, Aakash Kumar, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Pharmacology Research & Perspectives|October 3, 2024
Effect of mitochondrial coenzyme-Q10 precursor solanesol in gentamicin-induced experimental nephrotoxicity: Evidence from restoration of ETC-complexes and histopathological alterationsMinakshi Sangwan, Hema Chaudhary, Sidharth Mehan, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
RETRACTED: Rajkhowa et al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. <i>Pharmaceuticals</i> 2022, <i>15</i>, 959Bidisha Rajkhowa, Sidharth Mehan, Pranshul Sethi, et al.
Journal of Drug Targeting|February 8, 2024
Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategiesNitin Sharma, Balak Das Kurmi, Dilpreet Singh, et al.
European Journal of Medicinal Chemistry|September 18, 2024
Rationally designed febuxostat-based hydroxamic acid and its pH-Responsive nanoformulation elicits anti-tumor activityRitika, Zi-Yi Liao, Pin-Yu Chen, et al.
Molecules (Basel, Switzerland)|November 26, 2022
Effect of Natural Adenylcyclase/cAMP/CREB Signalling Activator Forskolin against Intra-Striatal 6-OHDA-Lesioned Parkinson's Rats: Preventing Mitochondrial, Motor and Histopathological DefectsMetab Alharbi, Abdulrahman Alshammari, Gurpreet Kaur, et al.
Current Pharmaceutical Design|January 27, 2025
Efficacy and Safety of Altibrain® as an Adjunctive Therapy for Autism Spectrum Disorder: An Open Label Trial Targeting Core SymptomsSidharth Mehan, Aakash Kumar, Prashant R Utage, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Exploring Azithromycin's Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory ModulationMohannad A Almikhlafi, Nehad A Abdallah, Aakash Kumar, et al.
Pageof 13